Comparison of the antibody responses to Plasmodium vivax and Plasmodium falciparum antigens in residents of Mandalay, Myanmar
Authors:
- Tong-Soo KimTKTong-Soo Kim
- Hyung-Hwan KimHKHyung-Hwan Kim
- Jung-Yeon KimJKJung-Yeon Kim
- Yoon KongYKYoon Kong
- Byoung-Kuk NaBNByoung-Kuk Na
- Khin LinKLKhin Lin
- Sung-Ung MoonSMSung-Ung Moon
- Yeon-Joo KimYKYeon-Joo Kim
- Myoung-Hee KwonMKMyoung-Hee Kwon
- Youngjoo SohnYSYoungjoo Sohn
- Hyuck KimHKHyuck Kim
- Hyeong-Woo LeeHLHyeong-Woo Lee
Open Access
- 6 August 2011
- journal article
- research article
- Published by Springer Nature in Malaria Journal
- Vol. 10 (1) , 228
Abstract
Background: The aim of this study was to investigate the profile of antibodies against several antigens of Plasmodium vivax and Plasmodium falciparum in Mandalay, Myanmar. Methods: Malaria parasites were identified by microscopic examination. To test the antibodies against P. vivax and P. falciparum in sera, an indirect immunofluorescence antibody test (IFAT) was performed using asexual blood parasite antigens. An enzyme-linked immunosorbent assay (ELISA) was performed with circumsporozoite protein (CSP), Pvs25 and Pvs28 recombinant proteins of transmission-blocking vaccine candidates for P. vivax, and liver stage specific antigen-1 and -3 (PfLSA-1, PfLSA-3) for P. falciparum. Results: Fourteen patients among 112 were found to be infected with P. vivax and 26 with P. falciparum by thick smear examination. Twenty-three patients were found to be infected with P. vivax, 19 with P. falciparum and five with both by thin smear examination. Blood samples were divided into two groups: Group I consisted of patients who were positive for infection by microscopic examination, and Group II consisted of those who showed symptoms, but were negative in microscopic examination. In P. falciparum, IgG against the blood stage antigen in Group I (80.8%) was higher than in Group II (70.0%). In P. vivax, IgG against the blood stage antigen in Group I (53.8%) was higher than in Group II (41.7%). However, the positivity rate of the PvCSP VK210 subtype in Group II (40.0%) was higher than in Group I (23.1%). Similarly for the PvCSP VK247 subtype, Group II (21.7%) was higher than that for Group I (9.6%). A similar pattern was observed in the ELISA using Pvs25 and Pvs28: positive rates of Group II were higher than those for Group I. However, those differences were not shown significant in statistics. Conclusions: The positive rates for blood stage antigens of P. falciparum were higher in Group I than in Group II, but the positive rates for antigens of other stages (PfLSA-1 and -3) showed opposite results. Similar to P. falciparum, the positive rate of pre-blood stage (CSP VK210 and 247 subtype) and post-blood stage (Pvs25 and 28) antigens of P. vivax were higher in Group II than in Group I. Therefore, sero-diagnosis is not helpful to discriminate between malaria patients and symptomatic individuals during the epidemic season in Myanmar.Keywords
This publication has 30 references indexed in Scilit:
- Molecular cloning and expression of the VK247 circumsporozoite protein for serodiagnosis of variant form Plasmodium vivaxParasitology Research, 2011
- Blocking Effect of a Monoclonal Antibody against Recombinant Pvs25 on Sporozoite Development in Anopheles sinensisClinical and Vaccine Immunology, 2010
- Application of the indirect fluorescent antibody assay in the study of malaria infection in the Yangtze River Three Gorges Reservoir, ChinaMalaria Journal, 2009
- High Levels of Antibodies to Plasmodium falciparum Liver Stage Antigen-1 in Naturally Infected Individuals in MyanmarThe Korean Journal of Parasitology, 2008
- Epidemiologic aspects of the malaria transmission cycle in an area of very low incidence in BrazilMalaria Journal, 2007
- Usefulness of the recombinant liver stage antigen-3 for an early serodiagnosis of Plasmodium falciparum infectionThe Korean Journal of Parasitology, 2006
- DNA Immunization byPlasmodium falciparumLiver-Stage Antigen 3 Induces Protection againstPlasmodium yoeliiSporozoite ChallengeInfection and Immunity, 2001
- A Region ofPlasmodium falciparumAntigen Pfs25 That Is the Target of Highly Potent Transmission-Blocking AntibodiesInfection and Immunity, 2000
- Cytotoxic T-Lymphocyte Epitopes for HLA-B53 and Other HLA Types in the Malaria Vaccine Candidate Liver-Stage Antigen 3Infection and Immunity, 2000
- Circumsporozoite Protein of Plasmodium vivax : Gene Cloning and Characterization of the Immunodominant EpitopeScience, 1985